Search results
Results from the WOW.Com Content Network
The Dr. Susan Love Research Foundation hopes to recruit one million women volunteers to become part of its participating "Army of Women". [21] [22] [23] Hua Eleanor Yu and her group are studying the involvement of STAT3 with cancer cells and the immune system, and developing possible drug treatments to attack tumor cells. [24] [25]
Sanford Burnham Prebys is a 501(c)(3) non-profit medical research institute focused on conducting basic and translational research. Its primary research areas include cancer, neurodegeneration, diabetes, infectious diseases, inflammatory conditions, and childhood illnesses.
The Pancreatic Cancer Action Network (PanCAN) is a United States–based 501(c)(3) charity that funds research, provides patient/caregiver support, conducts community outreach and advocates for increased federal research funding for those affected by pancreatic cancer. [4] [5]
In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis. [4] [5] In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare.
The company partnered with the Vall d'Hebron Institute of Oncology to launch the first blood-based cancer testing services in Barcelona in mid 2022. [44] Guardant Health also licensed cancer tests to the clinical laboratory company Adicon for research testing in China. [45] [46] In 2024 Guardant's Shield, colon cancer test received FDA approval ...
This page was last edited on 9 September 2023, at 00:10 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The Lustgarten Foundation is a 501(c)(3) non-profit organization foundation dedicated to advancing the research related to the diagnosis, treatment, cure and prevention of pancreatic cancer while raising public awareness and providing support to patients and their families. The Foundation is the largest private funder of pancreatic cancer ...
Pancreatic cancer is among the most deadly forms of cancer globally, with one of the lowest survival rates. In 2015, pancreatic cancers of all types resulted in 411,600 deaths globally. [8] Pancreatic cancer is the fifth-most-common cause of death from cancer in the United Kingdom, [19] and the third most-common in the United States. [20]